Enliven Therapeutics, Inc. (ELVN) Stock Price History
Historical prices from 2020 to 2026
Loading 10-year price history...
ELVN Historical Performance
Short-Term Returns
ELVN Stock Price Trajectory (2020–2026)
As of May 8, 2026, Enliven Therapeutics, Inc. (ELVN) trades at $40.29, representing a +120.5% return over the past year. The stock has delivered a +38.9% total return over five years (+6.8% CAGR), reflecting significant long-term value creation.
The stock reached its all-time high of $250.84 on June 9, 2020. From this peak, ELVN has corrected -83.9%, currently trading 59% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers KYMR (+190.7% 1Y), RVMD (+278.4% 1Y), and IMVT (+96.1% 1Y), ELVN has underperformed the peer group average. Compare ELVN vs KYMR →
ELVN Historical Price Data (2025–2026)
Showing 30 of 1,548 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 41.33 | 41.33 | 39.54 | 40.29 | 456K | -2.21% |
| 2026-05-06 | 41.84 | 42.33 | 40.76 | 41.20 | 340K | -0.91% |
| 2026-05-05 | 41.69 | 42.99 | 40.72 | 41.58 | 393K | -0.07% |
| 2026-05-04 | 41.71 | 42.16 | 41.16 | 41.61 | 341K | -0.22% |
| 2026-05-01 | 41.26 | 43.57 | 40.06 | 41.70 | 448K | +1.14% |
| 2026-04-30 | 42.35 | 43.43 | 40.69 | 41.23 | 807K | -2.76% |
| 2026-04-29 | 42.72 | 43.84 | 42.00 | 42.40 | 387K | -1.35% |
| 2026-04-28 | 44.84 | 45.31 | 42.77 | 42.98 | 612K | -4.28% |
| 2026-04-27 | 44.50 | 46.85 | 44.35 | 44.90 | 601K | +1.47% |
| 2026-04-24 | 44.00 | 44.53 | 43.26 | 44.25 | 615K | +0.82% |
| 2026-04-23 | 44.52 | 45.02 | 43.26 | 43.89 | 410K | -1.24% |
| 2026-04-22 | 46.44 | 46.93 | 44.14 | 44.44 | 731K | -3.16% |
| 2026-04-21 | 46.63 | 46.63 | 44.88 | 45.89 | 561K | -1.12% |
| 2026-04-20 | 47.74 | 48.15 | 46.40 | 46.41 | 484K | -3.53% |
| 2026-04-17 | 45.95 | 48.50 | 45.64 | 48.11 | 1.36M | +6.11% |
| 2026-04-16 | 43.84 | 45.80 | 42.64 | 45.34 | 1.48M | +3.16% |
| 2026-04-15 | 44.58 | 44.72 | 42.62 | 43.95 | 863K | -2.01% |
| 2026-04-14 | 43.93 | 45.35 | 43.84 | 44.85 | 721K | +2.33% |
| 2026-04-13 | 45.41 | 45.61 | 42.94 | 43.83 | 1.12M | -3.29% |
| 2026-04-10 | 45.66 | 46.30 | 44.65 | 45.32 | 1.09M | -0.59% |
| 2026-04-09 | 42.93 | 46.23 | 42.88 | 45.59 | 2.26M | +6.20% |
| 2026-04-08 | 44.13 | 44.67 | 42.45 | 42.93 | 1.20M | -0.53% |
| 2026-04-07 | 38.76 | 43.28 | 38.76 | 43.16 | 3.03M | +10.84% |
| 2026-04-06 | 39.47 | 40.42 | 38.74 | 38.94 | 698K | +0.28% |
| 2026-04-02 | 37.16 | 38.87 | 36.96 | 38.83 | 802K | +2.75% |
| 2026-04-01 | 39.57 | 40.00 | 37.56 | 37.79 | 825K | -3.60% |
| 2026-03-31 | 36.52 | 39.35 | 36.43 | 39.20 | 2.12M | +7.13% |
| 2026-03-30 | 38.34 | 39.22 | 35.60 | 36.59 | 1.99M | -5.77% |
| 2026-03-27 | 39.29 | 39.59 | 37.72 | 38.83 | 1.33M | -1.17% |
| 2026-03-26 | 35.66 | 40.58 | 35.66 | 39.29 | 3.38M | +10.58% |
See ELVN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ELVN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ELVN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonELVN — Frequently Asked Questions
Quick answers to the most common questions about buying ELVN stock.
How has ELVN stock performed recently?
ELVN returned +120.5% over the past year, beating its 5-year annualized CAGR of +6.8%. The stock trades above its 200-day moving average, confirming the uptrend.
What is ELVN's all-time high price?
Enliven Therapeutics, Inc. reached $250.84 on 2020-06-09. The 52-week high is $48.50. Current 1-year return of +120.5% places the stock closer to historical peaks.
Where can I download ELVN historical price data?
This page provides ELVN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.